查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828111

2025年全球藥物塗層球囊市場報告

Drug-Coated Balloons Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥物塗層球囊市場快速擴張，從2024年的10.8億美元成長到2025年的12.4億美元，複合年成長率為14.6%。預測期內的成長歸因於心血管疾病負擔的增加、對微創手術的需求、周邊動脈疾病（墊片）的流行、血管再阻塞介入性心臟病學的進步。

預計未來幾年藥物塗層球囊市場規模將快速成長，到2029年將達到22億美元，複合年成長率為15.5%。預測期內的成長可歸因於人口老化加劇、適應症和用途的拓展、對門診和門診護理的日益重視、與藥物輸送創新的融合以及全球健康計劃。預測期內的主要趨勢包括新製劑的監管核准、對副作用最小化的重視、生物可吸收塗層的出現、新興國家的市場擴張以及以患者為中心的理念。

藥物塗層球囊 (DCB) 是一種用於治療血管狹窄或阻塞的醫療設備，特別適用於介入性心臟病學和介入放射學。 DCB 的設計目的是在血管成形術的同時，將藥物直接輸送到血管病變部位。

藥物塗層球囊包括周邊動脈疾病、冠狀動脈疾病等疾病客製化的產品。周邊動脈疾病DCB是一種用於治療周邊動脈疾病（PAD）的特殊醫療設備，其特徵是心臟外和下肢血管狹窄或阻塞。 DCB使用多種類型的藥物，例如紫杉醇和Sirolimus，最終用戶包括醫院、心導管室和門診手術中心。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供藥物塗層球囊市場統計數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的藥物塗層球囊細分市場、市場趨勢和商機，以及您在藥物塗層球囊行業取得成功所需的數據。本藥物塗層球囊市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年15.5%的預測成長率，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自印度和墨西哥等主要地區的抗增殖藥物和球囊表面改質技術徵收關稅直接影響美國，從而導致血管內治療方案減少，動脈疾病治療成本上升。由於互惠關稅以及不斷升級的貿易摩擦和限制對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

冠狀動脈疾病 (CAD) 盛行率的不斷上升預計將推動藥物塗層球囊市場的未來成長。 CAD 是一種以供應心肌血液的冠狀動脈變窄或阻塞為特徵的疾病，常導致心臟病發作。藥物塗層球囊是用於治療冠狀動脈疾病的醫療設備。它們在手術過程中將藥物釋放到動脈中，以防止再血管再阻塞（血管成形術後動脈血管再阻塞）。例如，根據 2022 年 8 月發表在《美國心臟病學會雜誌》上的一項研究，預計 2025 年至 2060 年間美國普通人群的所有四種心血管風險因素都將增加。預計糖尿病增幅最大，為 39.3%，其次是血脂異常症（27.6%）、高血壓（25.1%）及肥胖（18.3%）。此外，心臟衰竭（33.4%）和缺血性心臟疾病（30.7%）的發病率預計將增加最大，心肌梗塞（16.9%）和中風（33.8%）的發生率也將增加最大。因此，冠狀動脈疾病盛行率的上升預計將推動藥物塗層球囊市場的發展。

預計門診手術中心數量的增加將推動藥物塗層球囊市場的成長。門診手術中心 (ASC) 是專門執行無需住院過夜手術的醫療機構。藥物塗層球囊在 ASC 中發揮重要作用，它與標準球囊相比，手術時間更短，可以提高患者吞吐量並降低營運成本。例如，VMG Health 在 2023 年 9 月報告稱，獲得醫療保險 (Medicare) 認證的門診手術中心總數將從 2021 年的 1,752 家增加 2.9% 至 2022 年的 1,804 家。因此，門診手術中心的普及率不斷提高正在推動藥物塗層球囊市場的擴張。

產品創新已成為藥物塗層球囊市場的關鍵趨勢。該領域的主要企業正專注於開發新技術和創新解決方案，以提升其市場地位。例如，美國醫療技術公司碧迪公司 (BD) 於2022年8月啟動了其周邊Sirolimus藥物塗層球囊 (DCB) 的 PREVISION 首次人體試驗。該試驗旨在評估SirolimusDCB 治療周邊動脈疾病患者的安全性和有效性，該疾病會顯著影響患者的運動能力和生活品質。

藥物塗層球囊領域的主要企業致力於技術進步，例如紫杉醇塗層球囊導管，以提高冠狀動脈支架內血管再阻塞等治療的有效性。這些進步旨在改善患者的治療效果，並最大限度地降低與傳統治療方法相關的併發症風險。紫杉醇塗層球囊導管是一種專用裝置，可在充氣時將藥物紫杉醇釋放到動脈壁中，有助於防止血管再阻塞成形術後再狹窄。例如，2024 年 3 月，美國醫療設備製造商波士頓科學公司的 AGENT™ 藥物塗層球囊 (DCB) 獲得美國食品藥物管理局(FDA) 的核准。該裝置專門用於治療冠狀動脈疾病患者的冠狀動脈支架內再血管再阻塞(ISR)，當先前植入支架的血管被斑塊或疤痕組織阻塞或變窄時就會發生這種情況。

2022年11月，美國介入性心血管技術製造商Cordis以11億美元收購了Med Alliance SA。 Cordis的目標是透過此次收購，到2027年為全球200萬名患者提供其藥物釋放型球囊Celtion SLR™（緩釋利莫司）。總部位於瑞士的Med Alliance SA是Sirolimus微囊藥物塗層球囊的開發商。

藥物塗層球囊市場的主要企業包括 Acotec Scientific AG、B.Braun Melsungen AG、Biosensors International Group Ltd、Medtronic Inc.、Boston Scientific Corporation、Opto Circuits、Concept Medical、Cardionovum GmbH、Endocor GmbH、Hexacath Sverige、iVasva Corporation、BIoTronik、Cook Medical、Cordis Corporation、Abbott Laboratories、Surmodics Inc.、Hexacath SAS、MicroPort、SurModics Inc. 和 Orchestra BioMed。

預計北美將成為2024年全球藥物塗層球囊市場最大的地區，並有望成為預測期內成長最快的地區。藥物塗層球囊市場報告涵蓋以下地區：亞太地區、西歐、東歐、北美、南美、中東和非洲。

藥物塗層球囊市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

藥物塗層球囊市場包括Everolimus和佐他莫司藥物塗層球囊的銷售。該市場的價值是指“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球藥物塗層氣球：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球藥物塗層球囊市場：成長率分析
  • 全球藥物塗層球囊市場表現：規模與成長，2019-2024
  • 全球藥物塗層球囊市場預測：規模與成長，2024-2029年，2034年
  • 全球藥物塗層球囊：總目標市場（TAM）

第6章 市場細分

  • 全球藥物塗層球囊市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 周邊動脈疾病
  • 冠狀動脈疾病
  • 其他
  • 全球藥物塗層球囊市場（按藥物類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 紫杉醇
  • Sirolimus
  • 全球藥物塗層球囊市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 心導管實驗室
  • 門診手術中心
  • 全球藥物塗層球囊市場：周邊動脈疾病細分、類型、績效及預測（2019-2024、2024-2029、2034）
  • 紫杉醇塗層球囊
  • Sirolimus塗層球囊
  • 全球藥物塗層球囊市場：冠狀動脈疾病細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 紫杉醇塗層球囊
  • Sirolimus塗層球囊
  • Everolimus塗層球囊
  • 全球藥物塗層球囊市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物塗層球囊治療股膕動脈病變
  • 用於治療腎動脈病變的藥物塗層球囊
  • 藥物塗層球囊和其他血管應用

第7章 區域和國家分析

  • 全球藥物塗層球囊市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球藥物塗層球囊市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 藥物塗層球囊市場：競爭格局
  • 藥物塗層球囊市場：公司簡介
    • Acotec Scientific AG
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd
    • Medtronic Inc.
    • Boston Scientific Corporation

第31章：其他領先和創新企業

  • Opto Circuits
  • Concept Medical
  • Cardionovum GmbH
  • Endocor GmbH
  • Hexacath Sverige
  • iVascular SLU
  • Minvasys SAS
  • MedAlliance
  • QT Vascular Ltd
  • Terumo Corporation
  • BIoTronik
  • Cook Medical
  • Cordis Corporation
  • Abbott Laboratories
  • Surmodics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年藥物塗裝球囊市場：提供新機會的國家
  • 2029年藥物塗裝球囊市場：細分領域帶來新機會
  • 2029年藥物塗層球囊市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24098u

A drug-coated balloon (DCB) is a medical device employed in the intervention of narrowed or obstructed blood vessels, particularly in interventional cardiology and interventional radiology. Its design facilitates the direct delivery of medication to the site of vascular disease while concurrently performing angioplasty.

The primary categories of products encompassed within drug-coated balloons include those tailored for peripheral artery disease, coronary artery disease, and other indications. Drug-coated balloons (DCBs) for peripheral artery disease are a specific type of medical device utilized in addressing peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of blood vessels outside the heart or in the lower extremities. Various drug types, such as paclitaxel and sirolimus, are employed, and the end-users encompass hospitals, cardiac catheterization labs, and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug-coated balloons market research report is one of a series of new reports from The Business Research Company that provides drug-coated balloons market statistics, including drug-coated balloons industry global market size, regional shares, competitors with a drug-coated balloons market share, detailed drug-coated balloons market segments, market trends and opportunities, and any further data you may need to thrive in the drug-coated balloons industry. This drug-coated balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-coated balloons market size has grown rapidly in recent years. It will grow from $1.08 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology.

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $2.2 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.

The forecast of 15.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on antiproliferative drug formulations and balloon surface modification technologies, sourced from key regions such as India and Mexico, which could lead to reduced endovascular treatment options and higher costs for arterial disease management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of coronary artery disease (CAD) is projected to drive the growth of the drug-coated balloons market in the future. CAD is a medical condition characterized by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle, often leading to heart attacks. Drug-coated balloons are medical devices used to treat coronary artery disease, releasing medication into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery following angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are expected to rise among the general U.S. population from 2025 to 2060. Diabetes is projected to see the most significant increase at 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. Additionally, the researchers found that rates of heart failure (33.4%) and ischemic heart disease (30.7%) are expected to experience the largest increases, along with heart attacks (16.9%) and strokes (33.8%). Consequently, the rise in coronary artery disease prevalence is anticipated to boost the drug-coated balloon market.

The increasing number of ambulatory surgery centers is anticipated to propel the growth of the drug-coated balloon market. Ambulatory Surgical Centers (ASCs) are medical facilities dedicated to conducting surgical procedures that do not necessitate an overnight hospital stay. Drug-coated balloons play a crucial role in ASCs by offering shorter procedure times compared to standard balloons, resulting in improved patient throughput and reduced operational costs. For instance, VMG Health reported in September 2023 that the total number of Medicare-certified ambulatory surgery centers increased by 2.9% from 1752 in 2021 to 1804 in 2022. Hence, the growing prevalence of ambulatory surgery centers is a driving force behind the drug-coated balloon market's expansion.

Product innovations are emerging as a significant trend in the drug-coated balloon market. Leading companies in this sector are concentrating on developing new technological and innovative solutions to enhance their market position. For example, in August 2022, Becton, Dickinson, and Company (BD), a U.S.-based medical technology firm, initiated the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). This trial is designed to evaluate the safety and effectiveness of the sirolimus DCB for treating patients with peripheral artery disease, a condition that greatly affects mobility and quality of life.

Leading companies in the drug-coated balloon sector are dedicated to advancing their technologies, including paclitaxel-coated balloon catheters, to improve treatment efficacy for conditions such as coronary in-stent restenosis. These advancements aim to enhance patient outcomes and minimize the risk of complications associated with traditional therapies. Paclitaxel-coated balloon catheters are specialized devices that release the drug paclitaxel into the artery wall upon inflation, helping to prevent re-narrowing after angioplasty. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for its AGENT(TM) Drug-Coated Balloon (DCB). This device is designed specifically for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease, which occurs when a previously stented blood vessel becomes obstructed or narrowed due to plaque or scar tissue.

In November 2022, Cordis, a US-based manufacturer of interventional cardiovascular technologies, completed the acquisition of Med Alliance SA for $1.1 billion. Through this acquisition, Cordis aims to globally provide the drug-eluting balloon SELUTION SLRTM (Sustained Limus Release) to two million patients by 2027. Med Alliance SA, based in Switzerland, is a developer of the sirolimus micro-reservoir drug-coated balloon.

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-coated balloons market consists of sales of everolimus and zotarolimus drug-coated balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug-Coated Balloons Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug-coated balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-coated balloons ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug-coated balloons market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Drug-Coated Balloons For Peripheral Artery Disease; Drug-Coated Balloons For Coronary Artery Disease; Drug-Coated Balloons For Other Indications
  • 2) By Drug Type: Paclitaxel; Sirolimus
  • 3) By End User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
  • 2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons; Everolimus-Coated Balloons
  • 3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions; Drug-Coated Balloons For Renal Artery Lesions; Drug-Coated Balloons For Other Vascular Applications
  • Companies Mentioned: Acotec Scientific AG; B. Braun Melsungen AG; Biosensors International Group Ltd; Medtronic Inc.; Boston Scientific Corporation; Opto Circuits; Concept Medical; Cardionovum GmbH; Endocor GmbH; Hexacath Sverige; iVascular SLU; Minvasys SAS; MedAlliance; QT Vascular Ltd; Terumo Corporation; Biotronik; Cook Medical; Cordis Corporation; Abbott Laboratories; Surmodics Inc.; Hexacath SAS; MicroPort; SurModics Inc.; Orchestra BioMed
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug-Coated Balloons Market Characteristics

3. Drug-Coated Balloons Market Trends And Strategies

4. Drug-Coated Balloons Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug-Coated Balloons Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug-Coated Balloons PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug-Coated Balloons Market Growth Rate Analysis
  • 5.4. Global Drug-Coated Balloons Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug-Coated Balloons Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug-Coated Balloons Total Addressable Market (TAM)

6. Drug-Coated Balloons Market Segmentation

  • 6.1. Global Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Peripheral Artery Disease
  • Drug-Coated Balloons For Coronary Artery Disease
  • Drug-Coated Balloons For Other Indications
  • 6.2. Global Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel
  • Sirolimus
  • 6.3. Global Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centers
  • 6.4. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Peripheral Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • 6.5. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • Everolimus-Coated Balloons
  • 6.6. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Femoropopliteal Lesions
  • Drug-Coated Balloons For Renal Artery Lesions
  • Drug-Coated Balloons For Other Vascular Applications

7. Drug-Coated Balloons Market Regional And Country Analysis

  • 7.1. Global Drug-Coated Balloons Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug-Coated Balloons Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug-Coated Balloons Market

  • 8.1. Asia-Pacific Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug-Coated Balloons Market

  • 9.1. China Drug-Coated Balloons Market Overview
  • 9.2. China Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug-Coated Balloons Market

  • 10.1. India Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug-Coated Balloons Market

  • 11.1. Japan Drug-Coated Balloons Market Overview
  • 11.2. Japan Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug-Coated Balloons Market

  • 12.1. Australia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug-Coated Balloons Market

  • 13.1. Indonesia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug-Coated Balloons Market

  • 14.1. South Korea Drug-Coated Balloons Market Overview
  • 14.2. South Korea Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug-Coated Balloons Market

  • 15.1. Western Europe Drug-Coated Balloons Market Overview
  • 15.2. Western Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug-Coated Balloons Market

  • 16.1. UK Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug-Coated Balloons Market

  • 17.1. Germany Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug-Coated Balloons Market

  • 18.1. France Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug-Coated Balloons Market

  • 19.1. Italy Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug-Coated Balloons Market

  • 20.1. Spain Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug-Coated Balloons Market

  • 21.1. Eastern Europe Drug-Coated Balloons Market Overview
  • 21.2. Eastern Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug-Coated Balloons Market

  • 22.1. Russia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug-Coated Balloons Market

  • 23.1. North America Drug-Coated Balloons Market Overview
  • 23.2. North America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug-Coated Balloons Market

  • 24.1. USA Drug-Coated Balloons Market Overview
  • 24.2. USA Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug-Coated Balloons Market

  • 25.1. Canada Drug-Coated Balloons Market Overview
  • 25.2. Canada Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug-Coated Balloons Market

  • 26.1. South America Drug-Coated Balloons Market Overview
  • 26.2. South America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug-Coated Balloons Market

  • 27.1. Brazil Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug-Coated Balloons Market

  • 28.1. Middle East Drug-Coated Balloons Market Overview
  • 28.2. Middle East Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug-Coated Balloons Market

  • 29.1. Africa Drug-Coated Balloons Market Overview
  • 29.2. Africa Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug-Coated Balloons Market Competitive Landscape And Company Profiles

  • 30.1. Drug-Coated Balloons Market Competitive Landscape
  • 30.2. Drug-Coated Balloons Market Company Profiles
    • 30.2.1. Acotec Scientific AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biosensors International Group Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug-Coated Balloons Market Other Major And Innovative Companies

  • 31.1. Opto Circuits
  • 31.2. Concept Medical
  • 31.3. Cardionovum GmbH
  • 31.4. Endocor GmbH
  • 31.5. Hexacath Sverige
  • 31.6. iVascular SLU
  • 31.7. Minvasys SAS
  • 31.8. MedAlliance
  • 31.9. QT Vascular Ltd
  • 31.10. Terumo Corporation
  • 31.11. Biotronik
  • 31.12. Cook Medical
  • 31.13. Cordis Corporation
  • 31.14. Abbott Laboratories
  • 31.15. Surmodics Inc.

32. Global Drug-Coated Balloons Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

34. Recent Developments In The Drug-Coated Balloons Market

35. Drug-Coated Balloons Market High Potential Countries, Segments and Strategies

  • 35.1 Drug-Coated Balloons Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug-Coated Balloons Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug-Coated Balloons Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer